In another study with SCCs, nuclear FAK was shown to downregulate the expression of insulin-like growth factor binding protein 3 (IGFBP3), a tumor suppressor, by promoting the interaction between the transcription factor RUNX1 and the transcriptional suppressor Sin3a17. The gene discussed is PTK2; the disease is neoplasm.